You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

melanoma cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Monitoring T Cell Responses in Melanoma, Lung and Other Cancer

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +9 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Oct 4, 2023

Gut and Tumor Microbiome in Advanced ER-positive and

Not yet recruiting
  • Breast Cancer
  • Melanoma
  • Observation
  • (no location specified)
Nov 6, 2023

Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)

Active, not recruiting
  • Tumor Skin
  • +2 more
  • OBX-115
  • Orlando, Florida
  • +1 more
Sep 28, 2023

Melanoma Trial in Beijing (IBI363)

Not yet recruiting
  • Melanoma
  • IBI363
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Oct 7, 2023

Prostate, Lung, Melanoma and Breast Cancer Patients Following

Recruiting
  • Prostate Cancer
  • +3 more
  • SBRT
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

PD-1 Refractory Advanced Melanoma Trial in Pittsburgh (Responder-Derived Fecal microbiota transplantation (R-FMT, Pembrolizumab,

Not yet recruiting
  • PD-1 Refractory Advanced Melanoma
  • Responder-Derived Fecal microbiota transplantation (R-FMT
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 1, 2023

Uveal Melanoma Trial in Grand Rapids (Darovasertib)

Recruiting
  • Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Jun 14, 2023

Melanoma Trial in Beijing, Nanjing, Hangzhou (OH2, Salvage chemo or best supportive care)

Recruiting
  • Melanoma
  • OH2
  • Salvage chemotherapy or best supportive care
  • Beijing, Beijing, China
  • +2 more
May 11, 2023

Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Nov 2, 2023

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

Melanoma Trial in Beijing City, Fuzhou City, Zhejiang (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Melanoma
  • Beijing City, China
  • +2 more
Dec 13, 2022

Metastatic, Melanoma, Non Small Cell Lung Cancer (NSCLC) Trial in Philadelphia (Radiotherapy, MEDI4736, Tremelimumab)

Active, not recruiting
  • Metastatic
  • +4 more
  • Radiotherapy
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jan 6, 2023

Melanoma Trial in Beijing (tunlametinib, paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin)

Not yet recruiting
  • Melanoma
  • tunlametinib
  • paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 15, 2023

Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 25, 2023

Improve Early Detection of Cancer Recurrence in High-Risk

Recruiting
  • Stage III Melanoma
  • Stage IV Cutaneous Melanoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Oct 6, 2022

    Melanoma, Breast Cancer, Oncology Trial in Saint-Petersburg

    Active, not recruiting
    • Melanoma
    • +7 more
      • Saint-Petersburg, Russian Federation
        N. N. Petrov Research Institute of oncology
      Sep 12, 2023

      Non-melanoma Skin Cancer Trial in Dresden (optical coherence tomography, in vivo reflectance confocal microscopy, 3D total body

      Completed
      • Non-melanoma Skin Cancer
      • optical coherence tomography, in vivo reflectance confocal microscopy, 3D total body photography
      • Dresden, Saxony, Germany
        Klinik und Poliklinik für Dermatologie, Carl Gustav Carus Dresde
      Apr 24, 2023

      Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)

      Not yet recruiting
      • Metastatic Melanoma
      • Skin Cancer
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      Mar 9, 2023

      Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma

      Recruiting
      • Clinical Stage 0 Cutaneous Melanoma AJCC v8
      • +43 more
      • Best Practice
      • +7 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 12, 2022

      Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

      Active, not recruiting
      • Melanoma
        • Murray, Utah
        • +1 more
        Feb 17, 2023

        Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

        Not yet recruiting
        • Clinical Stage III Cutaneous Melanoma AJCC v8
        • +4 more
        • Nashville, Tennessee
          Vanderbilt University/Ingram Cancer Center
        Feb 28, 2023

        Melanoma Stage III Trial in Shanghai (Toripalimab combined with Temozolomide)

        Not yet recruiting
        • Melanoma Stage III
        • Toripalimab combined with Temozolomide
        • Shanghai, China
          Fudan University Shanghai Cancer Center
        Apr 23, 2023

        Advanced Melanoma Trial in New Brunswick (Propranolol, Naltrexone)

        Not yet recruiting
        • Advanced Melanoma
        • New Brunswick, New Jersey
          Rutgers Cancer Institute of New Jersey
        Jul 18, 2023

        NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • +32 more
        • (no location specified)
        Mar 30, 2023

        NSCLC, Melanoma Trial (IMM60, Pembrolizumab)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Melanoma
        • (no location specified)
        Jan 24, 2023